Finance

Beta
Lists
NWRN:SWX
Newron Pharmaceuticals SpA
CHF 12.76
+5.28%
(+0.64) 1D
Jun 4, 5:30:15 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for NWRN...
Open
CHF 12.10
High
CHF 12.84
Low
CHF 11.72
Mkt. cap
252.95M
Avg. vol.
69.10K
Volume
89.42K
52-wk high
CHF 31.85
52-wk low
CHF 6.50
EPS
-CHF 0.61
Shares outstanding
20.81M
No. of employees
27
Open
CHF 12.10
High
CHF 12.84
Low
CHF 11.72
Mkt. cap
252.95M
Avg. vol.
69.10K
Volume
89.42K
52-wk high
CHF 31.85
52-wk low
CHF 6.50
EPS
-CHF 0.61
Shares outstanding
20.81M
No. of employees
27
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to NWRN in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for NWRN in the last 3 months.
Highest
Current CHF 12.76
CHF 44.00 (+244.83%)
Average
CHF 44.00 (+244.85%)
Lowest
CHF 44.00 (+244.83%)
News stories
From sources across the web
About Newron Pharmaceuticals SpA
CEOStefan Weber
Employees27
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitenewron.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
5.95M
5.95M
3.61M
3.61M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.04M
3.04M
4.52M
4.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.24M
2.24M
2.12M
2.12M
Operating expense
5.28M
5.28M
6.64M
6.64M
Total operating expenses
5.28M
5.28M
6.64M
6.64M
Operating income
672.50K
672.50K
-3.02M
-3.02M
Other non operating income
285.50K
285.50K
-2.14M
-2.14M
EBT including unusual items
-28.50K
-28.50K
-6.15M
-6.15M
EBT excluding unusual items
-28.50K
-28.50K
-6.15M
-6.15M
Income tax expense
8.00K
8.00K
434.50K
434.50K
Effective tax rate
-28.07%
-28.07%
-7.07%
-7.07%
Other operating expenses
-
-
-
-
Net income
-36.50K
-36.50K
-6.58M
-6.58M
Net profit margin
-0.61%
-0.61%
-182.15%
-182.15%
Earnings per share
-
-
-
-
Interest and investment income
149.00K
149.00K
120.50K
120.50K
Interest expense
-1.11M
-1.11M
-1.09M
-1.09M
Net interest expenses
-963.50K
-963.50K
-966.00K
-966.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
715.00K
715.00K
-3.00M
-3.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more